The Expected Impact of HPV Vaccination on the Accuracy of Cervical Cancer Screening: The Need for a Paradigm Change
Data up to Jan 2025
Total Citations Per Year
Abstract
References (42)
Human papillomavirus is a necessary cause of invasive cervical cancer worldwide
1999 • 8,737 citations
IARC Monographs on the Evaluation of Carcinogenic Risks to Humans
1995 • 8,575 citations
Sustained efficacy up to 4·5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomised control trial
2006 • 1,766 citations
Efficacy of a prophylactic adjuvanted bivalent L1 virus-like-particle vaccine against infection with human papillomavirus types 16 and 18 in young women: an interim analysis of a phase III double-blind, randomised controlled trial
2007 • 1,287 citations
Against which human papillomavirus types shall we vaccinate and screen? the international perspective
2004 • 1,099 citations
Accuracy of the Papanicolaou Test in Screening for and Follow-up of Cervical Cytologic Abnormalities
2000 • 1,089 citations
Overview of the European and North American studies on HPV testing in primary cervical cancer screening
2006 • 1,084 citations
Human Papillomavirus DNA versus Papanicolaou Screening Tests for Cervical Cancer
2007 • 1,031 citations
American Cancer Society Guideline for the Early Detection of Cervical Neoplasia and Cancer
2002 • 930 citations
2006 consensus guidelines for the management of women with abnormal cervical cancer screening tests
2007 • 831 citations
High sustained efficacy of a prophylactic quadrivalent human papillomavirus types 6/11/16/18 L1 virus-like particle vaccine through 5 years of follow-up
2006 • 803 citations
Epidemiologic Evidence and Human Papillomavirus Infection as a Necessary Cause of Cervical Cancer
1999 • 788 citations
Human Papillomavirus and Papanicolaou Tests to Screen for Cervical Cancer
2007 • 786 citations
Effect of Human Papillomavirus 16/18 L1 Viruslike Particle Vaccine Among Young Women With Preexisting Infection
2007 • 652 citations
Human papillomavirus DNA testing for the detection of cervical intraepithelial neoplasia grade 3 and cancer: 5-year follow-up of a randomised controlled implementation trial
2007 • 630 citations
Long term predictive values of cytology and human papillomavirus testing in cervical cancer screening: joint European cohort study
2008 • 613 citations
Effect of prophylactic human papillomavirus L1 virus-like-particle vaccine on risk of cervical intraepithelial neoplasia grade 2, grade 3, and adenocarcinoma in situ: a combined analysis of four randomised clinical trials
2007 • 581 citations
Projected Clinical Benefits and Cost-effectiveness of a Human Papillomavirus 16/18 Vaccine
2004 • 541 citations
Chapter 9: Clinical applications of HPV testing: A summary of meta-analyses
2006 • 538 citations
Human Papillomavirus Genotype Distribution in Low-Grade Cervical Lesions: Comparison by Geographic Region and with Cervical Cancer
2005 • 532 citations
Interim Guidance for the Use of Human Papillomavirus DNA Testing as an Adjunct to Cervical Cytology for Screening
2004 • 506 citations
Liquid Compared With Conventional Cervical Cytology
2008 • 423 citations
Evaluating Human Papillomavirus Vaccination Programs
2004 • 388 citations
Virologic Versus Cytologic Triage of Women With Equivocal Pap Smears: A Meta-analysis of the Accuracy To Detect High-Grade Intraepithelial Neoplasia
2004 • 364 citations
Potential Health and Economic Impact of Adding a Human Papillomavirus Vaccine to Screening Programs
2003 • 347 citations
Results at Recruitment From a Randomized Controlled Trial Comparing Human Papillomavirus Testing Alone With Conventional Cytology as the Primary Cervical Cancer Screening Test
2008 • 298 citations
Chapter 20: Issues in planning cervical cancer screening in the era of HPV vaccination
2006 • 235 citations
HPV testing in routine cervical screening: cross sectional data from the ARTISTIC trial
2006 • 200 citations
A cluster randomized controlled trial of visual, cytology and human papillomavirus screening for cancer of the cervix in rural India
2005 • 196 citations
Report on consensus conference on cervical cancer screening and management
2000 • 172 citations
Chapter 13: Primary Screening of Cervical Cancer With Human Papillomavirus Tests
2003 • 144 citations
Chapter 10: New dimensions in cervical cancer screening
2006 • 140 citations
Human Papillomavirus and Papanicolaou Tests to Screen for Cervical Cancer
2008 • 136 citations
Cervical cancer screening following prophylactic human papillomavirus vaccination
2008 • 123 citations
Visual inspection as a cervical cancer screening method in a primary health care setting in Africa
2006 • 113 citations
Routine cervical screening with primary HPV testing and cytology triage protocol in a randomised setting
2005 • 112 citations
Cervical Screening in the National Breast and Cervical Cancer Early Detection Program, 1995–2001
2004 • 69 citations
Optimization of primary and secondary cervical cancer prevention strategies in an era of cervical cancer vaccination: A multi-regional health economic analysis
2008 • 64 citations
Integration of Human Papillomavirus Vaccination and Cervical Cancer Screening in Latin America and the Caribbean
2008 • 55 citations
Screening and management of women and girls with human papillomavirus infection
2007 • 32 citations
Quality control for normal liquid‐based cytology: Rescreening, high‐risk HPV targeted reviewing and/or high‐risk HPV detection?
2008 • 21 citations
Deleted Work
1955 • 0 citations
Cited By (0)
No citing papers found in database